A shadow economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Experimental Drug Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Vendors market the substance there before redirecting customers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, physicians and chemists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.
Several professionals said the demand for the experimental drug could be connected to the increasing price of approved weight loss products such as Mounjaro.
Regulatory Status and Implementation
Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the British medical regulations.
Several content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, marketing, and consumer laws, risking fines, legal action or prison.
Service Response and Material Removal
According to TikTok, the platform has taken down violative material and prohibited associated hashtags and search suggestions. The organization stated it was dedicated to maintaining the platform secure and investing in strengthening compliance measures.
Digital Marketplace Operations
Investigations also found groups with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, populated with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at home.
Within moments of entering one community, a seller shared WhatsApp details, where most purchases take place. The vendor sent an guidebook and promised shipping within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about body mass, health issues or previous experience.
Product Information and Costs
Inside these groups, messages display dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically priced at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A representative for the messaging service said it actively monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering substances they cannot confirm. Even if the research behind retatrutide is sound, these online products may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to current price rises for approved slimming medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.
Her staff has previously seen individuals harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet authorized … may expose users to possibly serious health risks”.
